Skip to main content

Table 1 Patients’ characteristics

From: Impact on grafted kidney function of rocuronium-sugammadex vs cisatracurium-neostigmine strategy for neuromuscular block management. An Italian single-center, 2014-2017 retrospective cohort case-control study

Characteristic NEO (n = 175) SUG (n = 175) P value
Sex, M/F, n (%) 117 (66.9)/58(33.1) 104 (59.4)/71 (40.6) 0.184
Age, years [IQR] 52 [40.5-63] 52 [43.5-60] 0.654
Height, cm [IQR] 170 [165-176] 170 [164-176] 0.355
Weight, kg [IQR] 70 [62-80] 68 [55-78] 0.186
BMI, kg/m2 [IQR] 24.22 [22-26.2] 23.6 [20.4-26.1] 0.194
ASA, II/III/IV, n (%) 34 (19.4)/137(78.3)/4 (2.3) 26 (14.9)/148(84.6)/1 (0.6) 0.197
Neurovascular disease, n (%) 6 (3.4) 10 (5.7) 0.444
Respiratory disease, n (%) 18 (10.3) 26 (14.9) 0.195
• Obstructive, n (%) 8 (4.6) 11 (6.3) 0.638
• Other, n (%) 10 (5.7) 15 (8.6) 0.407
Cardiovascular disease, n (%) 137 (78.3) 147 (84) 0.219
• Hypertension, n (%) 124 (70.9) 130 (74.3) 0.549
• Other, n (%) 13 (7.9) 17 (9.7) 0.529
Abdominal disease, n (%) 63 (36) 79 (45.1) 0.102
Impaired glucose tolerance, n (%) 25 (14.3) 30 (17.1) 0.557
Dyslipidaemia, n (%) 30 (17.1) 32 (18.3) 0.889
Other disease, n (%) 16 (9.1) 13 (7.4) 0.699
Previous KTx, n (%) 18 (10.3) 16 (9.1) 0.857
  1. NMB neuromuscular block, NEO group of patients receiving neostigmine for reversal of cisatracurium-induced NMB, SUG group of patients receiving sugammadex for reversal of rocuronium-induced NMB, M male, F female, BMI body mass index, ASA American Society of Anesthesiologists physical status; neurovascular disease: history of transient ischemic attack, stroke, cerebral hemorrhage; respiratory disease: history of asthma, chronic obstructive pulmonary disease, or other diseases (restrictive lung diseases); cardiovascular disease: history of coronary artery disease, arrhythmia, heart failure, hypertension, disorders of the peripheral vascular system; abdominal disease: gastrointestinal disease (history of peptic ulcer, gastroesophageal reflux disease, irritable bowel syndrome, diverticular diseases, colitis, anal disease) and liver disease; other disease: rheumatic disease and musculoskeletal disease. Previous KTx previous kidney transplantation. Data are expressed as median [interquartile range, IQR] or number, n (%)